A Canadian research discovered that just about half of medical hashish customers with persistent ache stopped utilizing opioids

Article content continued

More on this subject

To get a complete picture, they considered demographics, patterns of cannabis use, long-term effectiveness of cannabis on pain, pain intensity, and pain-related interference values ​​at the start of the study and after three, six, and 12 months. Of the 757 people at the start of their studies, this number fell to 230 after six months and to 104 after twelve months.

Time was a “significant factor associated with improvements in pain intensity, pain-related interference scores, quality of life, and general health symptoms,” the abstract says.

The researchers confirmed that significant challenges in collecting long-term follow-up data from patients who have attempted cannabis products. “Even so, about a third of the patients in the study stayed on medicinal cannabis for six months, which reduced pain intensity and pain-related disorders while improving quality of life and general health symptoms.

The results are in line with numerous other studies, according to a contribution by the National Organization for Reform of the Marijuana Law (NORML).

The study’s authors found that many study participants switched from using herbal cannabis to consuming oil extracts during the course of the study, reports NORML. “The beneficial effects of cannabis appear to be long-term, and tolerance may not become a significant problem for patients on a stable regimen,” the blog quotes the researchers in conclusion.

“For many pain sufferers, cannabis offers a viable alternative to opioids that may improve their quality of life while also having a superior safety profile.” /. Photo by wildpixel / iStock / Getty Images Plus

NORML’s deputy director Paul Armentano considers the data from the study to be consistent and compelling. “For many pain sufferers, cannabis offers a viable alternative to opioids that may improve their quality of life and at the same time have a superior safety profile,” Armentano writes.

Another Canadian study published just last month found that cannabis use significantly reduced opioid use and improved quality of life. For those who used opioids, the daily amount of 152 mg morphine milligram equivalent (MME) at baseline fell 78 percent to 32.2 mg MME after six months.

“The high rate of cannabis use in chronic pain and the subsequent reduction in opioid use suggest that cannabis may play a role in harm reduction in the opioid overdose crisis and possibly improving patient quality of life and general public health,” the concluded Researcher.

Another recent study from Harvard Medical School, which enrolled nearly 250,000 chronic pain patients from 2011 to 2015, found that their cannabis use more than doubled during that period. “Given the projected increase in chronic pain of one in three people over the next two decades, versus the current rate of one in five, our results predict cannabis use is likely to increase even faster,” the study’s authors say.

Comments are closed.